References
- SchaffazickSRGuterresSSFreitasLLPohlmannARPhysicochemical characterization and stability of the polymeric nanoparticle systems for drug administrationQuím Nova200326726737
- Mora-HuertasCEFessiHElaissariAPolymer-based nanocapsules for drug deliveryInt J Pharm201038511314219825408
- MohanrajVGChenYNanoparticles: a reviewTrop J Pharm Res20065561573
- FontanaMCRezerJFCoradiniKLealDBBeckRCImproved efficacy in the treatment of contact dermatitis in rats by a dermatological nanomedicine containing clobetasol propionateEur J Pharm Biopharm20117924124921605671
- GuterresSSAlvesMPPohlmannARPolymeric nanoparticles, nanospheres and nanocapsules for cutaneous applicationsDrug Target Insights2007214715721901071
- ContriRVFielLAPohlmannARGuterresSSBeckRCTransport of substances and nanoparticles across the skin and in vitro models to evaluate skin permeation and/or penetrationBeckRGuterresSSPohlmannARNanocosmetics and Nanomedicines: New Approaches for Skin CareBerlin, GermanySpringer2011
- CastroGACoelhoALOliveiraCAMahechaGAOréficeRLFerreiraLAFormation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticlesInt J Pharm200938778319647057
- ShahKADateAAJoshiMDPatravaleVBSolid lipid nanoparticles (SLN) of tretinoin: potential in topical deliveryInt J Pharm200734516317117644288
- PoplePVSinghKKTargeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitisInt J Pharm201039816517820637847
- HaymanMKamPCACapsaicin: a review of its pharmacology and clinical applicationsCurr Anaesth Crit Care200819338343
- ZiPYangXHKuangHFYangYSYuLLEffect of HP beta CD on solubility and transdermal delivery of capsaicin through rat skinInt J Pharm200835815115818417302
- US Food Drug AdministrationCapsaicin 8% patch for the management of neuropathic pain associated with human immunodeficiency virus-associated peripheral neuropathy Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM290279.pdfAccessed November 17, 2013
- BarcelouxDGMedical Toxicology of Natural Substances: Foods, Fungi, Medicinal Herbs, Toxic Plants, and Venomous AnimalsHoboken, NJ, USAJohn Wiley & Sons2008
- KnotkovaHPappagalloMSzallasiACapsaicin (TRPV1 agonist) therapy for pain relief – farewell or revival?Clin J Pain20082414215418209521
- ContriRVKaiserMPolettoFSPohlmannARGuterresSSSimultaneous control of capsaicinoids release from polymeric nanocapsulesJ Nanosci Nanotechnol2011112398240621449399
- ContriRVKatzerTPohlmannARGuterresSSChitosan hydrogel containing capsaicinoids-loaded nanocapsules: an innovative formulation for topical deliverySoft Materials20108370385
- ContriRVKatzerTOuriqueAFCombined effect of polymeric nanocapsules and chitosan hydrogel on the effect of capsaicinoids adhesion to the skin surfaceJ Biomed Nanotechnol201410725743
- Bernkop-SchnürchADünnhauptSChitosan-based drug delivery systemsEur J Pharm Biopharm20128146346922561955
- WangJJZengZWXiaoRZRecent advances of chitosan nanoparticles as drug carriersInt J Nanomedicine2011676577421589644
- FessiHPuisieuxFDevissaguetJPAmmouryNBenitaSNanocapsule formation by interfacial polymer deposition following solvent displacementInt J Pharm198955R1R4
- SantosSSLorenzoniAFerreiraLMClotrimazole-loaded Eudragit® RS100 nanocapsules: preparation, characterization and in vitro evaluation of antifungal activity against Candida speciesMater Sci Eng C Mater Biol Appl2013331389139423827586
- KatzerTPohlmannARGuterresSSBeckRCDevelopment and optimization of polymeric nanocapsules intended for ophthalmic administrationAbstract presented at the XII International Macromolecular ColloquiumGramado, BrazilSeptember 7–10, 2010
- LinYKHuangZRZhuoRZFangJYCombination of calcipotriol and methotrexate in nanostructured lipid carriers for transdermal deliveryInt J Nanomedicine2010511712820309398
- RinaudoMChitin and chitosan: properties and applicationsProg Polym Sci200631603632
- Schmid-WendtnerMHKortingHCThe pH of the skin surface and its impact on the barrier functionSkin Pharmacol Physiol20061929630216864974
- CrossSEJiangRYBensonHARobertsMSCan increasing the viscosity of formulations be used to reduce the human skin penetration of the sunscreen oxybenzone?J Invest Dermatol200111714715011442762
- GreenBGMeasurement of sensory irritation of the skinAm J Contact Dermat20001117018011012006
- LeeEAnSChoiDMoonSChangIComparison of objective and sensory skin irritations of several cosmetic preservativesContact Dermatitis20075613113617295686
- NolanoMSimoneDAWendelschafer-CrabbGJohnsonTHazenEKennedyWRTopical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensationPain19998113514510353501
- YowHNWuXRouthAFGuyRHDye diffusion from microcapsules with different shell thickness into mammalian skinEur J Pharm Biopharm200972626819084062
- LeeCKUchidaTKitagawaKYagiAKimNSGotoSEffect of hydrophilic and lipophilic vehicles on skin permeation of tegafur, alclofenac and ibuprofen with or without permeation enhancersBiol Pharm Bull199316126412697907514
- HatanakaTKatayamaKKoizumiTSugibayashiKMorimotoYTime-dependent percutaneous-absorption enhancing effect of ethanolJ Control Release199533423428
- MagnussonBMKoskinenLODIn vitro percutaneous penetration of topically applied capsaicin in relation to in vivo sensation responsesInt J Pharm2000195556210675683